00:00:00Introduction
00:03:44Role of Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory (R/R) MM
00:27:00Role of BCMA- and Non-BCMA-Targeted Bispecific Antibodies in R/R MM
00:49:29Utility of Belantamab Mafodotin in R/R MM
01:07:01Potential Role of Cereblon E3 Ligase Modulators in MM